APA

Borthakur G., Dombret H., Schafhausen P., Brummendorf T. H., Boissel N., Jabbour E., Mariani M., Capolongo L., Carpinelli P., Davite C., Kantarjian H. & Cortes J. E. (20160209). A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy. : Haematologica.

Chicago

Borthakur Gautam, Dombret Herve, Schafhausen Philippe, Brummendorf Tim Henrik, Boissel Nicolas, Jabbour Elias, Mariani Mariangela, Capolongo Laura, Carpinelli Patrizia, Davite Cristina, Kantarjian Hagop and Cortes Jorge E. 20160209. A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy. : Haematologica.

Harvard

Borthakur G., Dombret H., Schafhausen P., Brummendorf T. H., Boissel N., Jabbour E., Mariani M., Capolongo L., Carpinelli P., Davite C., Kantarjian H. and Cortes J. E. (20160209). A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy. : Haematologica.

MLA

Borthakur Gautam, Dombret Herve, Schafhausen Philippe, Brummendorf Tim Henrik, Boissel Nicolas, Jabbour Elias, Mariani Mariangela, Capolongo Laura, Carpinelli Patrizia, Davite Cristina, Kantarjian Hagop and Cortes Jorge E. A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy. : Haematologica. 20160209.